Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30435 | 169 | 24.8 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
2418 | 2 | HYDROCHLOROTHIAZIDE//CICLETANINE//TORASEMIDE | 4143 |
30435 | 1 | CICLETANINE//5 AMINOLAEVULIC ACID//CA2 AND MG2 CONTENTS | 169 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CICLETANINE | authKW | 8441906 | 34% | 81% | 58 |
2 | 5 AMINOLAEVULIC ACID | authKW | 180683 | 1% | 100% | 1 |
3 | CA2 AND MG2 CONTENTS | authKW | 180683 | 1% | 100% | 1 |
4 | CAJAL CELLS PROPAGATION OF EXCITATION | authKW | 180683 | 1% | 100% | 1 |
5 | CARDIAC NUCLEOTIDES | authKW | 180683 | 1% | 100% | 1 |
6 | EICOSANOID SYSTEM | authKW | 180683 | 1% | 100% | 1 |
7 | ENDOTHELIAL ISOFORM OF NITRIC OXIDE SYNTHASE | authKW | 180683 | 1% | 100% | 1 |
8 | GLYCATION ADVANCED | authKW | 180683 | 1% | 100% | 1 |
9 | HOT EXCITATION SPOT | authKW | 180683 | 1% | 100% | 1 |
10 | LEFT ANTERIOR DESCENDING COROLLARY ARTERY | authKW | 180683 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1421 | 53% | 0% | 90 |
2 | Cardiac & Cardiovascular System | 889 | 29% | 0% | 49 |
3 | Peripheral Vascular Diseases | 811 | 21% | 0% | 35 |
4 | Physiology | 27 | 5% | 0% | 9 |
5 | Endocrinology & Metabolism | 14 | 5% | 0% | 8 |
6 | Chemistry, Medicinal | 9 | 3% | 0% | 5 |
7 | Medicine, General & Internal | 1 | 3% | 0% | 5 |
8 | Multidisciplinary Sciences | 1 | 1% | 0% | 1 |
9 | Geriatrics & Gerontology | 1 | 1% | 0% | 1 |
10 | Gastroenterology & Hepatology | 0 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SERV PHARMACOL PHARMACOCINET | 180683 | 1% | 100% | 1 |
2 | SECT INTERNAL MED DISABIL PREVENT | 45167 | 1% | 13% | 2 |
3 | OSCAR LANGENDORFF PHYSIOL | 29561 | 2% | 5% | 3 |
4 | IUP GENIE PHYSIOL INFORMAT | 16424 | 1% | 9% | 1 |
5 | BIOTECHNOL PL CARDIOVASC MED | 15055 | 1% | 8% | 1 |
6 | U400 | 11653 | 1% | 3% | 2 |
7 | CLIPPINGER S 136 | 10627 | 1% | 6% | 1 |
8 | RECH CARDIOL | 9508 | 1% | 5% | 1 |
9 | MED BROUSSAIS | 8602 | 1% | 5% | 1 |
10 | U337 | 8303 | 1% | 2% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 35412 | 11% | 1% | 19 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 7962 | 13% | 0% | 22 |
3 | AMERICAN JOURNAL OF HYPERTENSION | 6001 | 8% | 0% | 14 |
4 | JOURNAL OF APPLIED CARDIOLOGY | 5015 | 1% | 1% | 2 |
5 | TRACE ELEMENTS AND ELECTROLYTES | 3296 | 2% | 0% | 4 |
6 | ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 1823 | 5% | 0% | 8 |
7 | BULLETIN DE LA CLASSE DES SCIENCES ACADEMIE ROYALE DE BELGIQUE | 1367 | 1% | 1% | 1 |
8 | JOURNAL OF HYPERTENSION | 1188 | 5% | 0% | 8 |
9 | JOURNAL DE PHYSIOLOGIE | 1185 | 1% | 0% | 2 |
10 | CARDIOLOGY IN THE ELDERLY | 929 | 1% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KALINOWSKI, L , SZCZEPANSKA-KONKEL, M , JANKOWSKI, M , ANGIELSKI, S , (1999) CICLETANINE - NEW INSIGHTS INTO ITS PHARMACOLOGICAL ACTIONS.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 33. ISSUE 1. P. 7 -16 | 42 | 79% | 7 |
2 | CASTRO, A , HERNANDO, F , PARRA, L , PUERRO, M , ALEIXANDRE, A , FUENTES, JA , (1995) FURTHER EVIDENCE FOR A PERIPHERAL SYMPATHICOLYTIC ACTION OF THE ANTIHYPERTENSIVE CICLETANINE IN RATS.DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. VOL. 21. ISSUE 1. P. 29 -36 | 19 | 83% | 1 |
3 | JIN, HK , YANG, RH , OPARIL, S , (1992) CICLETANINE BLUNTS THE PULMONARY PRESSOR-RESPONSE TO ACUTE-HYPOXIA IN RATS.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 304. ISSUE 1. P. 14-19 | 20 | 69% | 4 |
4 | NASA, Y , YOSHIDA, H , URATA, M , UCHIBAYASHI, K , TSUNODA, Y , KAMIGATA, K , TAKEO, S , (1998) EFFECTS OF THE ANTIHYPERTENSIVE AGENT, CICLETANINE, ON NORADRENALINE RELEASE AND VASOCONSTRICTION IN PERFUSED MESENTERIC ARTERY OF SHR.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 123. ISSUE 3. P. 427-434 | 17 | 57% | 1 |
5 | YASU, T , IMANISHI, M , (1997) EFFECTS OF CICLETANINE ON PROSTAGLANDIN I-2 AND E-2 LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION.AMERICAN JOURNAL OF HYPERTENSION. VOL. 10. ISSUE 7. P. 750-755 | 12 | 80% | 0 |
6 | JIN, HK , YANG, RH , ESUNGE, P , CHEN, YF , DURAND, J , OPARIL, S , (1991) ANTIHYPERTENSIVE EFFECT OF CICLETANINE IS EXAGGERATED IN NACL-SENSITIVE HYPERTENSION.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 301. ISSUE 6. P. 383-389 | 17 | 71% | 6 |
7 | MIKKELSEN, EO , SEHESTED, J , POULSEN, SH , (1993) COMPARISON OF INVITRO EFFECTS OF CICLETANINE, ITS ENANTIOMERS AND MAJOR METABOLITE ON RAT THORACIC AORTA.NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. VOL. 347. ISSUE 5. P. 548-552 | 14 | 70% | 2 |
8 | VARGAS, F , ALVAREZ-GUERRA, M , DROY-LEFAIX, MT , GARAY, RP , (1998) INHIBITION BY (-)-CICLETANINE OF THE VASCULAR REACTIVITY TO ANGIOTENSIN II AND VASOPRESSIN IN ISOLATED RAT VESSELS.AMERICAN JOURNAL OF HYPERTENSION. VOL. 11. ISSUE 5. P. 579-584 | 8 | 100% | 2 |
9 | KALINOWSKI, L , SZCZEPANSKAKONKEL, M , JANKOWSKI, M , ANGIELSKI, S , (1997) MODULATION BY LOW SODIUM INTAKE OF GLOMERULAR RESPONSE TO CICLETANINE AND ATRIAL NATRIURETIC FACTOR.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 121. ISSUE 4. P. 635 -642 | 15 | 50% | 3 |
10 | ALVAREZGUERRA, M , ALDA, O , MORIN, E , ALLARD, M , GARAY, RP , (1996) REDUCTION BY (-)-CICLETANINE OF THE VASCULAR REACTIVITY TO ANGIOTENSIN II IN RATS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 28. ISSUE 4. P. 564-570 | 10 | 71% | 7 |
Classes with closest relation at Level 1 |